More Starpharma Holdings Limited news
Starpharma Holdings LimitedASX: SPL

ARC grant for Starpharmas targeted drug delivery

Mar 30, 2016 at 5:31 AM EDT · Issued by Starpharma Holdings Limited

Filed with ASX · Mar 30, 2016 at 5:31 AM EDT

On 6ix: 6ix.com/news/arc-grant-for-starpharmas-targeted-drug-delivery

View Attachment

6ix hasn’t read this filing yet.

Starpharma Holdings Limited on 6ix

Earlier from Starpharma

  • VivaGel condom receives TGA device certificationMar 30, 2016
  • VivaGel-coated condom approved for marketing in JapanMar 30, 2016
  • Starpharma Interim Report and Half-year Financial ResultsMar 30, 2016
  • Starpharma completes A$18 million placement, SPP to followMar 30, 2016
  • Starpharma commences Dendrimer-Docetaxel clinical trialMar 30, 2016

Later from Starpharma

  • Dendrimers improve anticancer efficacy lung metastasis modelMar 30, 2016
  • SPL docetaxel superior to Taxotere across multiple cancersMar 30, 2016
  • Starpharma presenting at Bell Potter LifeScience ConferenceMar 30, 2016
  • Starpharma signs cancer drug agreement with AstraZenecaMar 30, 2016
  • Starpharma to recoup $6 million cash for overseas R&DMar 30, 2016
All Starpharma news releases↗

Follow Starpharma into a list and get an email when it puts out news.

Follow Starpharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer